Investor Relations

To Our Stakeholders

Sales and income increased, centering on double-digit sales increases in overseas regions.

The Americas, EMEA* and All Other Geographic Regions Deliver Double-Digit Sales Increases
Sharply Higher Income, Benefiting from Effects of Higher Sales and Yen Depreciation

During the first six months of the fiscal year ending March 31, 2015, the Sysmex Group recorded an increase in net sales compared with the first six months of the preceding fiscal year, with sales growth centered on overseas regions. Income also rose substantially, due to the impact of higher sales, as well as yen depreciation. Net sales rose 17.9% year on year, with operating income up 46.6%, ordinary income up 46.2% and net income up 48.2%. At the exchange rates prevailing one year earlier, net sales would have been up 13.5% and operating income up 22.6%.

In Japan, sales in the immunochemistry field expanded, but overall sales were flat, due in part to the impact of the consumption tax hike. All overseas geographic regions posted double-digit sales increases, with the Americas and EMEA regions delivering particularly favorable results. In addition to higher sales in the hematology and hemostasis fields, the inclusion of Partec GmbH and Inostics GmbH as consolidated subsidiaries contributed to the substantial sales increase in EMEA. Owing to the growth in overseas sales, the Group's overseas sales ratio amounted to 80.8%.

Regarding our consolidated financial forecast for the full fiscal year ending March 31, 2015, although sales are moving essentially in line with our expectations, given the income results during the first half we now anticipate higher levels of operating income, ordinary income and net income than previously forecast. (Our consolidated financial forecast for the fiscal year ending March 31, 2015, is for net sales of ¥210.0 billion, operating income of ¥41.0 billion, ordinary income of ¥40.7 billion and net income of ¥24.9 billion.)

With regard to dividends, we now plan to increase both interim and year-end dividends by ¥2 each compared with our initial forecast (of interim and year-end dividends of ¥14 each), bringing the total for the year to ¥32 per share, and we intend to maintain stable dividend levels going forward.

* Europe, the Middle East and Africa

Hisashi Ietsugu
Chairman and CEO


Related Links
 - Presentation
 - Financial Data
 - Financial Statement


President and CEO Hisashi Ietsugu
November 2014 
Hisashi Ietsugu
Chairman and CEO
Hisashi Ietsugu

Top of Investor Relation

Sysmex Corporation

Copyright© SYSMEX CORPORATION, All Rights Reserved.